Ads
related to: lcis breast cancer survival rate- Clinical Trial Results
Learn About Clinical Trial Results
In Patients Like Yours.
- Request A Rep
Request a Representative & Discover
More About Treatment Option.
- Resources
Access Tools & Resources Available
To Help You Learn About A Treatment
- Clinical Trial Design
Learn More About Clinical Trial
And Study Results Today.
- Oncology Co-Pay Program
Downloadable Resources Available
For Your Patients And Practice
- Ordering Information
Find Out More About Ordering
A Treatment For Your Patients.
- Clinical Trial Results
Search results
Results From The WOW.Com Content Network
The overall 5-year survival rate of lobular carcinoma in situ has been estimated to be 97%. [16] LCIS (lobular neoplasia is considered pre-cancerous) is an indicator (marker) identifying women with an increased risk of developing invasive breast cancer. This risk extends more than 20 years.
Invasive lobular carcinoma (ILC) is breast cancer arising from the lobules of the mammary glands. [1] It accounts for 5–10% of invasive breast cancer. [2] [3] Rare cases of this carcinoma have been diagnosed in men (see male breast cancer). [4]
Breast cancer classification divides breast ... (LCIS). Stages 1–3 are within the breast or regional lymph nodes. ... and their intrinsically worse survival rate ...
A new study says a double mastectomy doesn't increase the rates of surviving breast cancer. Here's what study authors and doctors say this means for patients.
The trial included 325 patients from across 28 countries.
The American Cancer Society reports 5-year relative survival rates of over 70% for women with stage 0-III breast cancer with a 5-year relative survival rate close to 100% for women with stage 0 or stage I breast cancer. The 5-year relative survival rate drops to 22% for women with stage IV breast cancer. [3]
Ads
related to: lcis breast cancer survival rate